V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220019428 | 220007483 | 1.61 | null | Curative (C) | 2016-03-27 | 2016-04-23 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220028901 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019431 | 220021888 | 1.8 | 90 | Disease modification (D) | 2014-06-30 | 2015-03-10 | Dasatinib | 99 | null | 220028936 | DASATINIB |
| 220019433 | 220007498 | null | 64.2 | Curative (C) | 2017-03-27 | 2017-03-30 | Dasatinib | N | null | 220028965 | DASATINIB |
| 220019434 | 220007505 | 1.67 | 78 | Curative (C) | 2014-06-26 | 2014-06-28 | Rituximab | N | null | 220028983 | RITUXIMAB |
| 220019435 | 220007509 | 1.51 | 81.6 | Curative (C) | 2014-11-03 | 2014-12-29 | AML18 PILOT TRIAL | N | N | 220028990 | PILOT TRIAL |
| 220019436 | 220007516 | 1.67 | 52.6 | Neo-adjuvant (N) | null | 2015-06-06 | AML 18 TRIAL | Y | N | 220028997 | AML18 TRIAL |
| 220019437 | 220007516 | 1.59 | 70.6 | Curative (C) | 2017-12-10 | 2018-03-22 | AML18 PILOT TRIAL | N | N | 220028997 | PILOT TRIAL |
| 220019438 | 220007526 | 1.67 | 83 | Curative (C) | 2016-07-23 | 2016-07-23 | Dasatinib | N | N | 220029037 | DASATINIB |
| 220019439 | 220007528 | null | null | Curative (C) | 2017-08-12 | 2017-08-15 | Dasatinib | N | null | 220029043 | DASATINIB |
| 220019441 | 220007539 | 1.85 | 75.6 | Disease modification (D) | 2015-02-20 | 2015-04-03 | AML18 PILOT TRIAL | N | N | 220029091 | PILOT TRIAL |
| 220019442 | 220017713 | 1.7 | 68.7 | Disease modification (D) | 2018-12-13 | 2018-12-14 | AML 18 TRIAL | Y | N | 220029098 | AML18 TRIAL |
| 220019443 | 220007548 | 1.66 | 53 | Disease modification (D) | 2018-03-08 | 2018-03-14 | Alemtuz+Fludara+Melphalan RIC MUD | 2 | N | 220029118 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019444 | 220007551 | 0 | 51.5 | Disease modification (D) | 2014-07-26 | 2014-07-26 | AML18 PILOT TRIAL | null | N | 220029122 | PILOT TRIAL |
| 220019446 | 220007555 | 1.66 | 54.5 | null | 2015-10-27 | 2015-11-13 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220029134 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019447 | 220021522 | null | 107.5 | Palliative (P) | 2015-03-04 | 2015-03-10 | AML 18 TRIAL | Y | N | 220029166 | AML18 TRIAL |
| 220019449 | 220007567 | 1.79 | 89.5 | Curative (C) | 2017-01-22 | 2017-01-29 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220029179 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019450 | 220014167 | 1.7 | 79.3 | Curative (C) | 2017-12-03 | 2017-12-18 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220029191 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019451 | 220007579 | 1.8 | 82.8 | null | 2019-03-25 | 2019-05-06 | AML18 PILOT TRIAL | 99 | N | 220029242 | PILOT TRIAL |
| 220019452 | 220007582 | 1.71 | 95.2 | Curative (C) | 2017-08-14 | 2017-08-17 | AML18 PILOT TRIAL | N | N | 220029268 | PILOT TRIAL |
| 220019453 | 220007584 | 1.66 | 116.8 | Palliative (P) | 2015-08-18 | 2015-08-19 | AML 18 TRIAL | Y | null | 220029273 | AML18 TRIAL |
| 220019454 | 220007588 | 1.57 | 63.99 | Disease modification (D) | 2018-02-08 | 2018-02-16 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220029292 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019455 | 220007595 | 1.85 | 90.35 | Curative (C) | 2019-01-03 | 2019-01-04 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220029327 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019457 | 220007618 | null | null | Curative (C) | 2017-04-13 | 2017-04-13 | AML 18 TRIAL | Y | null | 220029437 | AML18 TRIAL |
| 220019458 | 220007622 | 1.67 | 99.7 | Palliative (P) | 2014-06-08 | 2014-06-08 | Dasatinib | 02 | N | 220029445 | DASATINIB |
| 220019459 | 220007629 | 0 | 95.1 | null | 2014-07-05 | 2014-07-05 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 220029454 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019460 | 220007635 | null | 89.3 | Curative (C) | 2016-06-23 | 2016-08-04 | AML18 PILOT TRIAL | Y | N | 220029467 | PILOT TRIAL |
| 220019461 | 220007638 | 1.79 | 96.6 | Curative (C) | 2015-09-07 | 2015-10-23 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | null | 220029470 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019462 | 220007651 | null | 80.9 | Curative (C) | 2014-01-23 | 2014-01-23 | AML18 PILOT TRIAL | Y | N | 220029514 | PILOT TRIAL |
| 220019464 | 220019739 | 1.66 | 88.9 | Palliative (P) | 2016-08-02 | 2016-08-06 | Dasatinib | N | N | 220029559 | DASATINIB |
| 220019465 | 220007662 | 1.7 | 72.5 | Curative (C) | 2013-07-31 | 2013-11-09 | AML 18 TRIAL | Y | N | 220029586 | AML18 TRIAL |
| 220019466 | 220014221 | 1.87 | 54.7 | Curative (C) | 2016-10-08 | 2016-10-09 | AML18 PILOT TRIAL | 01 | N | 220029599 | PILOT TRIAL |
| 220019467 | 220007671 | 0 | 84.9 | Disease modification (D) | 2015-03-03 | 2015-03-03 | Rituximab | 2 | N | 220029606 | RITUXIMAB |
| 220019468 | 220007673 | 1.7 | 74.9 | Disease modification (D) | 2017-12-18 | 2017-12-20 | Rituximab | N | N | 220029608 | RITUXIMAB |
| 220019469 | 220007676 | 1.85 | 0 | Curative (C) | 2015-07-01 | 2016-07-28 | Dasatinib | 02 | N | 220029610 | DASATINIB |
| 220019470 | 220007679 | 1.87 | 68.9 | null | 2018-04-24 | 2018-06-19 | Dasatinib | N | null | 220029630 | DASATINIB |
| 220019471 | 220007689 | 1.55 | null | Curative (C) | 2014-03-17 | 2014-03-24 | Rituximab | N | null | 220029664 | RITUXIMAB |
| 220019472 | 220007690 | 1.63 | 67.6 | Curative (C) | 2013-11-25 | 2013-11-25 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 220029667 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019473 | 220007692 | null | 63.6 | Curative (C) | 2014-12-14 | 2014-12-21 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | N | 220029672 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019474 | 220007706 | 0 | 73 | null | 2017-02-15 | 2017-02-21 | AML 18 TRIAL | 01 | N | 220029704 | AML18 TRIAL |
| 220019475 | 220007708 | 0 | 81.9 | Disease modification (D) | 2013-08-01 | 2013-08-15 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | null | null | 220029714 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019476 | 220007712 | 0 | null | null | 2016-11-02 | 2016-11-26 | Rituximab | N | N | 220029738 | RITUXIMAB |
| 220019477 | 220007715 | 1.88 | 101.4 | Curative (C) | 2017-05-30 | 2017-12-03 | Dasatinib | 2 | N | 220029746 | DASATINIB |
| 220019478 | 220014245 | 1.75 | 0 | Palliative (P) | 2015-01-29 | 2015-01-29 | Dasatinib | 2 | N | 220029749 | DASATINIB |
| 220019479 | 220007723 | 1.58 | 51.7 | Curative (C) | 2016-09-07 | 2016-10-11 | Rituximab | null | N | 220029756 | RITUXIMAB |
| 220019480 | 220007724 | 0 | 76.6 | Curative (C) | 2016-01-11 | 2016-01-11 | AML 18 TRIAL | Y | N | 220029760 | AML18 TRIAL |
| 220019481 | 220017779 | 1.75 | 63.8 | Disease modification (D) | 2017-10-08 | 2017-10-09 | Dasatinib | N | N | 220029762 | DASATINIB |
| 220019482 | 220007729 | null | null | Curative (C) | 2015-09-01 | 2015-09-06 | Alemtuz+Fludara+Melphalan RIC MUD | N | null | 220029771 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019483 | 220007732 | null | 64.8 | Curative (C) | 2017-12-06 | 2018-01-05 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 220029775 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 220019484 | 220007734 | 1.7 | null | Palliative (P) | 2019-01-10 | 2019-01-11 | Dasatinib | 02 | N | 220029778 | DASATINIB |
| 220019485 | 220007745 | 1.6 | 64.9 | Disease modification (D) | null | 2016-05-25 | AML18 PILOT TRIAL | null | null | 220029817 | PILOT TRIAL |